In particular, PBMC-DNA derived from AAA patients appears to increase the transcription of AIM2 in THP-1 macrophages within 1–6 h, i.e. it acts at a very early stage of the innate immune response even in the absence of priming agents such as LPS. Here, AIM2 is linked to triple-A syndrome.